STOCK TITAN

ISRAEL ACQ CORP A (ISRLF) Financials

ISRLF
FY2025 annual
Revenue Not reported for FY2025
Net Income -$510K -118.1% YoY
EPS (Diluted) Not reported for FY2025
Operating Cash Flow -$258K -107.7% YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ISRLF SEC filings page.

This page shows ISRAEL ACQ CORP A (ISRLF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ISRLF FY2025

The dominant mechanic is balance-sheet contraction alongside uneven earnings-to-cash conversion, not an operating-growth story.

Between FY2023 and FY2025, total assets contracted from $154.5M to $10.0M, a scale-down that changes the balance-sheet context. Negative equity widened to $8.0M in FY2025, so shrinking assets did not repair capitalization and liabilities still exceeded assets.

The liquidity cushion narrowed sharply: current ratio fell from 12.0x in FY2024 to 1.2x in FY2025, leaving much less room between short-term resources and obligations. The latest balance sheet is therefore close to fully committed to current claims rather than carrying the broad cushion visible in FY2024.

FY2024 paired positive net income with positive operating cash flow, but FY2025 paired a net loss of -$510K with operating cash flow of -$258K. The FY2023 mismatch—positive net income alongside negative operating cash flow—shows that earnings quality has varied, so one year's profit figure is not a complete read on cash generation.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

ISRAEL ACQ CORP A does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
2/6

ISRAEL ACQ CORP A passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality No Cash Backing
N/A

ISRAEL ACQ CORP A reported a net loss of $510K while operations used $258K of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income
-$65K
YoY+72.7%
QoQ+62.4%

ISRAEL ACQ CORP A reported -$65K in net income in Q2 2026. This represents an increase of 72.7% from the same quarter a year earlier. Against the prior quarter it is up 62.4%.

Revenue

Not reported for Q2 2026.

EBITDA

Not reported for Q2 2026.

EPS (Diluted)

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt
$2K
YoY-97.0%
QoQ-94.7%

ISRAEL ACQ CORP A held $2K in cash as of Q2 2026; long-term debt is not reported for that period.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Shares Outstanding

Not reported for Q2 2026.

Margins & Returns

None of these metrics is reported for Q2 2026.

Capital Allocation

Share Buybacks
$0
QoQ-100.0%

ISRAEL ACQ CORP A repurchased no shares in Q2 2026. Against the prior quarter it is down 100.0%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

ISRLF Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ISRLF quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Income-$127K+63.8%-$245K+12.8%N/A-$281K-19.9%-$349K-18.9%-$281K+55.5%N/A-$234K-26.2%
Net Income-$65K+72.7%-$173K-359.4%N/A-$180K-122.2%-$238K-132.2%$67K-88.4%N/A$811K-54.2%

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, EBITDA, Interest Expense, Income Tax, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

ISRLF Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ISRLF quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$6.4M-33.7%$6.4M-32.8%$10.0M-87.9%$9.9M-87.9%$9.7M-88.0%$9.5M-88.1%$82.6M-46.5%$81.6M-46.6%
Current Assets$6.4M-33.7%$6.4M-32.8%$10.0M-87.9%$9.9M-87.9%$9.7M-88.0%$9.5M-88.1%$82.6M-46.5%$81.6M-46.6%
Cash & Equivalents$2K-97.0%$33K+19.8%$7K-67.4%$64K+138.9%$57K-14.4%$27K-91.5%$21K-96.8%$27K-96.7%
Short-Term Investments$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0
Total Liabilities$14.8M-13.9%$14.6M-11.9%$18.0M-79.9%$17.8M-79.8%$17.2M-80.1%$16.6M-80.5%$89.5M-43.9%$88.0M-44.0%
Current Liabilities$8.4M+10.0%$8.3M+15.0%$8.0M+16.6%$8.0M+23.4%$7.6M+22.9%$7.2M+18.5%$6.9M+21.4%$6.5M+17.1%
Non-Current Liabilities$6.4M-33.0%$6.3M-32.5%$9.9M-88.0%$9.8M-88.0%$9.6M-88.1%$9.4M-88.1%$82.6M-46.3%$81.5M-46.3%
Total Equity-$8.4M-11.4%-$8.2M-16.1%-$8.0M-16.5%-$7.9M-22.3%-$7.5M-24.0%-$7.1M-26.3%-$6.9M-41.3%-$6.5M-42.0%
Retained Earnings-$8.4M-11.4%-$8.3M-16.9%-$8.1M-18.7%-$7.9M-22.3%-$7.5M-24.0%-$7.1M-26.3%-$6.9M-41.3%-$6.5M-42.0%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

ISRLF Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ISRLF quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$20K+66.4%-$82K+38.9%$38K-95.6%-$103K-112.1%-$59K-107.5%-$134K-115.8%$865K+186.3%$855K+2722.6%
Investing Cash Flow-$71K+60.9%$3.6M-$178K+83.7%-$184K+84.6%-$182K+84.6%N/A-$1.1M-148.4%-$1.2M-1955.8%
Financing Cash Flow$60K-77.8%-$3.5M$84K-62.8%$294K-2.1%$271K+80.6%N/A$225K$300K
Share Buybacks$0$3.7M$0$0$0N/A$0$0

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid.

ISRLF Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ISRLF quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Return on Assets-1.0%+1.5pp-2.7%-3.4ppN/A-1.8%-2.8pp-2.5%-3.4pp0.7%0.0ppN/A1.0%-0.2pp
Current Ratio0.76-0.5x0.77-0.5x1.24-10.8x1.23-11.3x1.27-11.7x1.32-11.8x12.01-15.3x12.53-14.9x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Asset Turnover, FCF Margin.

Note: Shareholder equity is negative (-$8.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Frequently Asked Questions

Is ISRAEL ACQ CORP A profitable?

No, ISRAEL ACQ CORP A (ISRLF) reported a net income of -$510K in fiscal year 2025.

What is ISRAEL ACQ CORP A's operating cash flow?

ISRAEL ACQ CORP A (ISRLF) recorded an outflow of $258K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are ISRAEL ACQ CORP A's total assets?

ISRAEL ACQ CORP A (ISRLF) had $10.0M in total assets as of fiscal year 2025, including both current and long-term assets.

ISRAEL ACQ CORP A (ISRLF) had 1M shares outstanding as of fiscal year 2025.

ISRAEL ACQ CORP A (ISRLF) had a current ratio of 1.24 as of fiscal year 2025, which is considered adequate.

ISRAEL ACQ CORP A (ISRLF) had a return on assets of -5.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

ISRAEL ACQ CORP A (ISRLF) has negative shareholder equity of -$8.0M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

ISRAEL ACQ CORP A (ISRLF) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

ISRAEL ACQ CORP A (ISRLF) reported a net loss of $510K while operations used $258K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top